1. Xiao JB, Leng AM, Zhang YQ, Wen Z, He J, Ye GN. CUEDC2:multifunctional roles in carcinogenesis. Front Biosci (Landmark Ed).2019;24(5):935-946. doi:10.2741/4759
2. Gajendran M, Loganathan P, Jimenez G, et al. A comprehensivereview and update on ulcerative colitis. Dis Mon. 2019; 65(12):100851.doi:10.1016/j.disamonth.2019.02.004
3. Sokic-Milutinovic A. Appropriate management of attenuated familialadenomatous polyposis: report of a case and review of the literature.Dig Dis. 2019;37(5):400-405. doi:10.1159/000497207
4. Allen J, Sears CL. Impact of the gut microbiome on the genome andepigenome of colon epithelial cells: contributions to colorectal cancerdevelopment. Genome Med. 2019;11(1):11. doi:10.1186/s13073-019-0621-2
5. Snyder C, Hampel H. Hereditary colorectal cancer syndromes. SeminOncol Nurs. 2019;35(1):58-78. doi:10.1016/j.soncn.2018.12.011
6. Célind J, Ohlsson C, Bygdell M, Nethander M, Kindblom JM.Childhood body mass index is associated with risk of adult coloncancer in men: an association modulated by pubertal change in bodymass index. Cancer Epidemiol Biomarkers Prev. 2019;28(5):974-979.doi:10.1158/1055-9965.EPI-18-1077
7. Pedersen JK, Rosholm JU, Ewertz M, Engholm G, Lindahl-Jacobsen R,Christensen K. Declining cancer incidence at the oldest ages: Hallmarkof aging or lower diagnostic activity?. J Geriatr Oncol. 2019;10(5):792-798. doi:10.1016/j.jgo.2019.02.001
8. Batool R, Jamal K, Sheroze MW, et al. Clinical features of colorectalcarcinoma at the Jinnah Postgraduate Medical Centre, Karachi,Pakistan: a cross-sectional study. J Med Res Health Sci. 2022;5(9):2203-2209. doi: 10.52845/JMRHS/2022-5-9-1
9. T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Türkiye Kanserİstatistikleri, Ankara 2017. [Internet] https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri. Erişim: 14.8.21.
10. Singh N, Baby D, Rajguru JP, Patil PB, Thakkannavar SS, PujariVB. Inflammation and cancer. Ann Afr Med. 2019;18(3):121-126.doi:10.4103/aam.aam_56_18
11. Tuomisto AE, Mäkinen MJ, Väyrynen JP. Systemic inflammationin colorectal cancer: Underlying factors, effects, and prognosticsignificance. World J Gastroenterol. 2019;25(31):4383-4404. doi:10.3748/wjg.v25.i31.4383
12. Rosner MH, Dalkin AC. Electrolyte disorders associated with cancer.Adv Chronic Kidney Dis. 2014;21(1):7-17. doi:10.1053/j.ackd.2013.05.005
13. Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK. Hyponatremia inhospitalized cancer patients and its impact on clinical outcomes. Am JKidney Dis. 2012;59(2):222-228. doi:10.1053/j.ajkd.2011.08.029
14. Zhang L, Wang Z, Xiao J, et al. Sodium to globulin ratio as aprognostic factor for patients with advanced gastric cancer. J Cancer.2020;11(24):7320-7328. doi:10.7150/jca.47314
15. Lopes G, Stern MC, Temin S, et al. Early detection for colorectalcancer: ASCO Resource-Stratified Guideline. J Glob Oncol. 2019;5:1-22.doi:10.1200/JGO.18.00213
16. Chen W, Xin S, Xu B. Value Research of NLR, PLR, and RDW inprognostic assessment of patients with colorectal cancer. J Healthc Eng.2022;2022:7971415. doi:10.1155/2022/7971415
17. Ulanja MB, Rishi M, Beutler BD, et al. Colon cancer sidedness,presentation, and survival at different stages. J Oncol. 2019;2019:4315032.doi:10.1155/2019/4315032
18. Wang L, Wilson SE, Stewart DB, Hollenbeak CS. Marital status andcolon cancer outcomes in US Surveillance, Epidemiology and EndResults registries: does marriage affect cancer survival by genderand stage?. Cancer Epidemiol. 2011;35(5):417-422. doi:10.1016/j.canep.2011.02.004
19. Chowdhury S, Mainwaring P, Zhang L, et al. Systematic review andmeta-analysis of correlation of progression-free survival-2 and overallsurvival in solid tumors. Front Oncol. 2020;10:1349. doi:10.3389/fonc.2020.01349
20. Peach G, Kim C, Zacharakis E, Purkayastha S, Ziprin P. Prognosticsignificance of circulating tumour cells following surgical resection ofcolorectal cancers: a systematic review. Br J Cancer. 2010;102(9):1327-1334. doi:10.1038/sj.bjc.6605651
21. Benitez Majano S, Di Girolamo C, Rachet B, et al. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway,and Sweden: a population-based study. Lancet Oncol. 2019;20(1):74-87.doi:10.1016/S1470-2045(18)30646-6
22. Arhin ND, Shen C, Bailey CE, et al. Surgical resection and survivaloutcomes in metastatic young adult colorectal cancer patients. CancerMed. 2021;10(13):4269-4281. doi:10.1002/cam4.3940
23. Yu Z, Chen Z, Wu J, Li Z, Wu Y. Prognostic value of pretreatmentserum carbohydrate antigen 19-9 level in patients with colorectalcancer: A meta-analysis. PLoS One. 2017;12(11):e0188139. doi:10.1371/journal.pone.0188139
24. Stokkel LE, van Rossum HH, van de Kamp MW, et al. Clinical valueof preoperative serum tumor markers CEA, CA19-9, CA125, andCA15-3 in surgically treated urachal cancer. Urol Oncol. 2023;S1078-1439(23)00045-5. doi:10.1016/j.urolonc.2023.01.018
25. Basbug M, Arikanoglu Z, Bulbuller N, et al. Prognostic value ofpreoperative CEA and CA 19-9 levels in patients with colorectal cancer.Hepatogastroenterology. 2011;58(106):400-405.
26. Narita Y, Taniguchi H, Komori A, et al. CA19-9 level as a prognostic andpredictive factor of bevacizumab efficacy in metastatic colorectal cancerpatients undergoing oxaliplatin-based chemotherapy. Cancer ChemotherPharmacol. 2014;73(2):409-416. doi:10.1007/s00280-013-2367-7
27. Martini F, Guadagni F, Lenti L, et al. CA 19-9 monosialogangliosidecontent of human colorectal tumor cells correlates with tumor cell-induced platelet aggregation. Anticancer Res. 2000;20(3A):1609-1614.
28. Sun DW, An L, Lv GY. Albumin-fibrinogen ratio and fibrinogen-prealbumin ratio as promising prognostic markers for cancers: anupdated meta-analysis. World J Surg Oncol. 2020;18(1):9. doi:10.1186/s12957-020-1786-2
29. Hara K, Aoyama T, Yamada T, et al. The prognostic value of theperioperative systemic inflammation score for patients with advancedgastric cancer. Anticancer Res. 2020;40(3):1503-1512. doi:10.21873/anticanres.14095
30. Xu J, Chen X, Wang X, et al. Preoperative hyponatremia andhypocalcemia predict poor prognosis in elderly gastric cancer patients.Cancer Manag Res. 2019;11:8765-8780. doi:10.2147/CMAR.S211603
31. House CD, Vaske CJ, Schwartz AM, et al. Voltage-gated Na+ channelSCN5A is a key regulator of a gene transcriptional network thatcontrols colon cancer invasion. Cancer Res. 2010;70(17):6957-6967.doi:10.1158/0008-5472.CAN-10-1169
32. Scheipner L, Smolle MA, Barth D, et al. The AST/ALT ratio is anindependent prognostic marker for disease-free survival in stage IIand III colorectal carcinoma. Anticancer Res. 2021;41(1):429-436.doi:10.21873/anticanres.14792
33. Jiang Z, Li C, Zhao Z, et al. Abnormal liver function induced by space-occupying lesions is associated with unfavorable oncologic outcomein patients with colorectal cancer liver metastases. Biomed Res Int.2018;2018:9321270. doi:10.1155/2018/9321270
34. Park JS, Park HC, Choi DH, et al. Prognostic and predictive value of livervolume in colorectal cancer patients with unresectable liver metastases.Radiat Oncol J. 2014;32(2):77-83. doi:10.3857/roj.2014.32.2.77